Standout Papers

Brain insulin resistance in type 2... 2004 2026 2011 2018 1.0k
  1. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums (2018)
    Steven E. Arnold, Zoe Arvanitakis et al. Nature Reviews Neurology
  2. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment (2011)
    Suzanne Craft Archives of Neurology
  3. Effects of Aerobic Exercise on Mild Cognitive Impairment (2010)
    Laura D. Baker, Laura L. Frank et al. Archives of Neurology
  4. Intranasal insulin improves cognition and modulates β-amyloid in early AD (2007)
    Mark A. Reger, G. Stennis Watson et al. Neurology
  5. Insulin and neurodegenerative disease: shared and specific mechanisms (2004)
    Suzanne Craft, G. Stennis Watson The Lancet Neurology
  6. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease (2006)
    Marcus E. Risner, Ann M. Saunders et al. The Pharmacogenomics Journal
  7. Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype (2005)
    Mark A. Reger, G. Stennis Watson et al. Neurobiology of Aging
  8. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches (2020)
    Derek Kellar, Suzanne Craft The Lancet Neurology
  9. Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes (2010)
    Laura D. Baker, Donna J. Cross et al. Archives of Neurology
  10. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment (2019)
    Ravinder Nagpal, Bryan J. Neth et al. EBioMedicine
  11. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease (2014)
    Heather M. Snyder, Roderick A. Corriveau et al. Alzheimer s & Dementia
  12. Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia (2015)
    Amy Claxton, Laura D. Baker et al. Journal of Alzheimer s Disease
  13. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement (2017)
    Eugene J. Barrett, Zhenqi Liu et al. The Journal of Clinical Endocrinology & Metabolism
  14. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia (2020)
    Suzanne Craft, Rema Raman et al. JAMA Neurology
  15. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial (2023)
    Mitzi M. Gonzales, Valentina R. Garbarino et al. Nature Medicine

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 100 standout
Sub-graph 1 of 19

Citing Papers

From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Single-cell multiregion dissection of Alzheimer’s disease
2024 StandoutNature

Works of Suzanne Craft being referenced

Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
2023 Standout
Pathological correlates of dementia in a longitudinal, population‐based sample of aging
2007

Author Peers

Author Last Decade Papers Cites
Suzanne Craft 12386 4321 5696 5676 329 26.8k
Geert Jan Biessels 7081 5340 2446 4427 429 25.2k
Lenore J. Launer 12728 12877 3994 3322 605 42.1k
Elaine R. Peskind 7742 5502 4731 1572 293 22.4k
Murray A. Raskind 6577 5033 3235 1868 275 22.1k
Ralph N. Martins 15324 8366 6959 1847 579 28.4k
Steven E. Arnold 9870 7659 5221 1343 336 27.3k
Sudha Seshadri 7338 6690 3873 1739 463 29.7k
Phillip A. Low 10758 1798 3342 2135 454 34.5k
Walter A. Rocca 6735 9903 3103 3675 342 32.1k
Eva L. Feldman 15662 755 10757 7932 564 39.9k

All Works

Loading papers...

Rankless by CCL
2026